Citrate is widely used as a
food additive being part of virtually all processed foods. Although considered inert by most of the regulatory agencies in the world, plasma
citrate has been proposed to play immunometabolic functions in multiple tissues through altering a plethora of cellular pathways. Here, we used a short-term alimentary intervention (24 hours) with standard chow supplemented with
citrate in amount corresponding to that found in processed foods to evaluate its effects on
glucose homeostasis and liver physiology in C57BL/6J mice. Animals supplemented with dietary
citrate showed
glucose intolerance and
insulin resistance as revealed by
glucose and
insulin tolerance tests. Moreover, animals supplemented with
citrate in their food displayed fed and fasted
hyperinsulinemia and enhanced insulin secretion during an oral
glucose tolerance test.
Citrate treatment also amplified
glucose-induced insulin secretion in vitro in INS1-E cells.
Citrate supplemented animals had increased liver PKCĪ± activity and altered phosphorylation at
serine or
threonine residues of components of
insulin signaling including IRS-1, Akt,
GSK-3 and FoxO1. Furthermore,
citrate supplementation enhanced the hepatic expression of lipogenic genes suggesting increased de novo lipogenesis, a finding that was reproduced after
citrate treatment of hepatic FAO cells. Finally, liver
inflammation markers were higher in
citrate supplemented animals. Overall, the results demonstrate that dietary
citrate supplementation in mice causes
hyperinsulinemia and
insulin resistance both in vivo and in vitro, and therefore call for a note of caution on the use of
citrate as a
food additive given its potential role in metabolic dysregulation.